Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Killock

Showing results (41-50 of 304) with videos related to

Pageof 31
Sort By:
Nature Reviews. Clinical Oncology|March 16, 2016
Pancreatic cancer: A problem quartered--new subtypes, new solutions?David Killock
Nature Reviews. Clinical Oncology|April 1, 2016
New technology: Integrated approach to genetic profiling of blood cancersDavid Killock
Nature Reviews. Clinical Oncology|July 21, 2017
Lung Cancer: Frontline nivolumab - CheckMate 026 ends in stalemateDavid Killock
Nature Reviews. Clinical Oncology|August 23, 2017
Genetics: Conditional selection determines the pathways of cancer evolutionDavid Killock
Nature Reviews. Clinical Oncology|September 1, 2017
Cell signalling: Even kinase-inactive BRAF is oncogenicDavid Killock
Nature Reviews. Clinical Oncology|July 19, 2017
Breast cancer: Profiling of ultra-low-risk diseaseDavid Killock
Nature Reviews. Clinical Oncology|June 9, 2016
Immunotherapy: Study deciphers enigmatic mechanism of PD-L1 overexpressionDavid Killock
Nature Reviews. Clinical Oncology|December 6, 2017
Lung cancer: Osimertinib strengthens the frontlineDavid Killock
Nature Reviews. Clinical Oncology|September 6, 2017
Breast cancer: Short-term NAT reveals resistanceDavid Killock
Nature Reviews. Clinical Oncology|October 18, 2017
Skin cancer: Propranolol limits melanoma recurrenceDavid Killock
Pageof 31

Showing results (41-50 of 304) with videos related to

Sort By:
Pageof 31
Nature Reviews. Clinical Oncology|March 16, 2016
Pancreatic cancer: A problem quartered--new subtypes, new solutions?David Killock
Nature Reviews. Clinical Oncology|April 1, 2016
New technology: Integrated approach to genetic profiling of blood cancersDavid Killock
Nature Reviews. Clinical Oncology|July 21, 2017
Lung Cancer: Frontline nivolumab - CheckMate 026 ends in stalemateDavid Killock
Nature Reviews. Clinical Oncology|August 23, 2017
Genetics: Conditional selection determines the pathways of cancer evolutionDavid Killock
Nature Reviews. Clinical Oncology|September 1, 2017
Cell signalling: Even kinase-inactive BRAF is oncogenicDavid Killock
Nature Reviews. Clinical Oncology|July 19, 2017
Breast cancer: Profiling of ultra-low-risk diseaseDavid Killock
Nature Reviews. Clinical Oncology|June 9, 2016
Immunotherapy: Study deciphers enigmatic mechanism of PD-L1 overexpressionDavid Killock
Nature Reviews. Clinical Oncology|December 6, 2017
Lung cancer: Osimertinib strengthens the frontlineDavid Killock
Nature Reviews. Clinical Oncology|September 6, 2017
Breast cancer: Short-term NAT reveals resistanceDavid Killock
Nature Reviews. Clinical Oncology|October 18, 2017
Skin cancer: Propranolol limits melanoma recurrenceDavid Killock
Pageof 31